16 Results for "

1-NM-PP1

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "1-NM-PP1" in MCE Product Catalog:

7
7 Cited Publications
Cat. No.: HY-13942
CAS No.: 221244-14-0
Purity:  99.17%
Synonyms: PP1 Analog II
Target:  

Src

Research Areas:  

Cancer

1-NM-PP1, a cell-permeable PP1 analog, is a potent Src family kinases inhibitor with IC50s of 4.3 nM and 3.2 nM for v-Src-as1 and c-Fyn-as1, respectively .
loading...
    loading...
9
9 Publications Verification
Cat. No.: HY-108599
CAS No.: 28399-31-7
Purity:  ≥98.0%
Synonyms: FR236924
Research Areas:  

Neurological Disease

DCP-LA (FR236924), a linoleic acid derivative, selectively and directly activates PKCε. DCP-LA activates Ca( 2+)/calmodulin-dependent protein kinase II (CaMKII) and inhibits protein phosphatase-1 (PP-1) to stimulate AMPA receptor exocytosis. DCP-LA inhibits activation of caspase-3/-9 and protects neurons at least in part from oxidative stress-induced apoptosis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-13941
CAS No.: 221243-82-9
Purity:  98.96%
Synonyms: 1-NA-PP 1
Target:  

Src PKD

1-Naphthyl PP1 (1-NA-PP 1) is a selective inhibitor of src family kinases and Protein Kinase D. 1-Naphthyl PP1 inhibits v-Src and c-Fyn, c-Abl, CDK2 and CAMK II with IC50s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-13941B
CAS No.: 956025-47-1
Purity:  99.83%
Synonyms: 1-NA-PP 1 hydrochloride
Target:  

Src PKD

1-Naphthyl PP1 hydrochloride (1-NA-PP 1 hydrochloride) is a selective inhibitor of src family kinases and Protein Kinase D. 1-Naphthyl PP1 hydrochloride inhibits v-Src and c-Fyn, c-Abl, CDK2 and CAMK II with IC50s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-102069
CAS No.: 956025-83-5
Purity:  99.66%
Research Areas:  

Others

3MB-PP1, a bulky purine analog, is a Polo-like kinase 1 (Plk1) inhibitor. 3MB-PP1 blocks mitotic progression and cell division arise through target Plk1 in in cells expressing analog-sensitive Plk1 alleles. 3MB-PP1 specifically inhibits the activity of analog-sensitive Ssn3 (Cdk8). 3MB-PP1 inhibits Leu93 Mutant Zipper-interacting protein kinase (Leu93-ZIPK; IC50=2 μM). 3MB-PP1 can be used for the research of hypha formation of Candida albicans and cell division .
loading...
    loading...
Cat. No.: HY-151374
CAS No.: 2227110-54-3
Purity:  99.58%
Target:  

PKD

Research Areas:  

Cancer

3-IN-PP1 is a protein kinase D (PKD) inhibitor. 3-IN-PP1 has potent pan-PKD inhibitory activity for PKD1, PKD2 and PKD3 with IC50 values of 108, 94 and 108 nM, respectively. 3-IN-PP1 also is a broad spectrum anticancer agent and has inhibition of several tumor cells growth. 3-IN-PP1 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-130514
CAS No.: 327081-00-5
Target:  

HIV CDK

Research Areas:  

Infection

SMAPP1 is an activator of protein phosphatase-1 (PP1). SMAPP1 increases phosphorylation of CDK9’s Ser90 and Thr186 residues, but not Ser175. SMAPP1 induces HIV-1 replication, upregulates HIV-1 transcription that led to the reactivation of latent HIV-1 provirus .
loading...
    loading...
Cat. No.: HY-115741
CAS No.: 956025-99-3
Purity:  ≥99.0%
3BrB-PP1 is an ATP-competitive analog. 3BrB-PP1 can specifically inhibit the activity of protein kinase with mutations in the ATP-binding pocket (mutation of Thr97 within Sty1’s ATP-binding pocket) .
loading...
    loading...
Cat. No.: HY-108599R
CAS No.: 28399-31-7
Synonyms: FR236924 (Standard)
DCP-LA (Standard) is the analytical standard of DCP-LA. This product is intended for research and analytical applications. DCP-LA (FR236924), a linoleic acid derivative, selectively and directly activates PKCε. DCP-LA activates Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) and inhibits protein phosphatase-1 (PP-1) to stimulate AMPA receptor exocytosis. DCP-LA inhibits activation of caspase-3/-9 and protects neurons at least in part from oxidative stress-induced apoptosis[1][2][3].
loading...
    loading...
Cat. No.: HY-172708
Target:  

Liposome

Research Areas:  

Neurological Disease

DSPE-PEG2000-PP1 is a PEG compound which composed of DSPE and a PP1 peptide. PP1 peptide targets the inflammatory atherosclerotic plaque. DSPE-PEG2000-PP1 can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-172708A
Target:  

Liposome

Research Areas:  

Neurological Disease

DSPE-PEG3400-PP1 is a PEG compound which composed of DSPE and a PP1 peptide. PP1 peptide targets the inflammatory atherosclerotic plaque. DSPE-PEG3400-PP1 can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-102069R
CAS No.: 956025-83-5
Research Areas:  

Others

3MB-PP1 (Standard) is the analytical standard of 3MB-PP1 (HY-102069). This product is intended for research and analytical applications. 3MB-PP1, a bulky purine analog, is a Polo-like kinase 1 (Plk1) inhibitor. 3MB-PP1 blocks mitotic progression and cell division arise through target Plk1 in in cells expressing analog-sensitive Plk1 alleles. 3MB-PP1 specifically inhibits the activity of analog-sensitive Ssn3 (Cdk8). 3MB-PP1 inhibits Leu93 Mutant Zipper-interacting protein kinase (Leu93-ZIPK; IC50=2 μM). 3MB-PP1 can be used for the research of hypha formation of Candida albicans and cell division .
loading...
    loading...
Cat. No.: HY-187648
CAS No.: 167698-72-8
Synonyms: p-Nitrophenyl phosphorothioate cyclohexanamine
Target:  

Phosphatase

Research Areas:  

Others

pNPPT cyclohexanamine (p-Nitrophenyl phosphorothioate cyclohexanamine) is a dianionic aryl thiophosphate monoester substrate of PP1γ (protein phosphatase 1γ). PP1γ catalyzes the hydrolysis of pNPPT cyclohexanamine .
loading...
    loading...
Cat. No.: HY-172707
Target:  

Liposome

Research Areas:  

Neurological Disease

DSPE-PEG1000-PP1 is a PEG compound which composed of DSPE and a PP1 peptide. PP1 peptide targets the inflammatory atherosclerotic plaque. DSPE-PEG1000-PP1 can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-172709
Target:  

Liposome

Research Areas:  

Neurological Disease

DSPE-PEG5000-PP1 is a PEG compound which composed of DSPE and a PP1 peptide. PP1 peptide targets the inflammatory atherosclerotic plaque. DSPE-PEG5000-PP1 can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-187407A
Synonyms: DOPE-PEG2000-Mal-Cys-LSLERFLRCWSDAPA
Research Areas:  

Others

DOPE-PEG2000-PP1 (DOPE-PEG2000-Mal-Cys-LSLERFLRCWSDAPA) is an amphiphilic lipid-PEG-peptide conjugate consisting of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the PP1 peptide. PP1 peptide functions as a targeting ligand for specific cell or tissue recognition. DOPE-PEG2000-PP1 is used for targeted drug delivery through functionalization of liposomes and lipid nanoparticles.
loading...
    loading...
  • 1